Loss-of-function mutations in the retinoblastoma gene <i>RB1</i> are common in several treatment-refractory cancers such as small-cell lung cancer and triple-negative breast cancer. To identify drugs synthetic lethal with <i>RB1</i> mutation (<i>RB1</i> <sup>mut</sup>), we tested 36 cell-cycle inhib...
No comments yet
Be the first to share your thoughts!